Journal Article

STING: a master regulator in the cancer-immunity cycle

Zhu, Yuanyuan, An, Xiang, Zhang, Xiao, Qiao, Yu, Zheng, Tongsen, Li, Xiaobo

2019

Overview

The aberrant appearance of DNA in the cytoplasm triggers the activation of cGAS-cGAMP-STING signaling and induces the production of type I interferons, which play critical roles in activating both innate and adaptive immune responses. Recently, numerous studies have shown that the activation of STING and the stimulation of type I IFN production are critical for the anticancer immune response. However, emerging evidence suggests that STING also regulates anticancer immunity in a type I IFN-independent manner. For instance, STING has been shown to induce cell death and facilitate the release of cancer cell antigens. Moreover, STING activation has been demonstrated to enhance cancer antigen presentation, contribute to the priming and activation of T cells, facilitate the trafficking and infiltration of T cells into tumors and promote the recognition and killing of cancer cells by T cells. In this review, we focus on STING and the cancer immune response, with particular attention to the roles of STING activation in the cancer-immunity cycle. Additionally, the negative effects of STING activation on the cancer immune response and non-immune roles of STING in cancer have also been discussed.

• Publisher: BioMed Central,BioMed Central Ltd,BMC
• Subject: Animals / Antigens / Antigens, Neoplasm / B cells / Biomedical and Life Sciences / Biomedicine / Cancer / Cancer Research / Care and treatment / Cell death / Disease Susceptibility - immunology / Gene Expression Regulation, Neoplastic / Humans / Immune response / Immunity, Innate / Immunomodulation / Immunotherapy / Interferon / Interferon Type I - metabolism / Membrane Proteins - genetics / Membrane Proteins - metabolism / Neoplasms - etiology / Neoplasms - metabolism / Neoplasms - pathology / Neoplasms - therapy / Oncology / Review / Signal Transduction / T cells